Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy.
Nobumichi TanakaYasushi NakaiIsao AsakawaKaori YamakiMakito MiyakeShunta HoriHideaki MiyakeTomomi FujiiKiyohide FujimotoPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)
LDR-BT can achieve a higher recurrence-free survival with an adequate local radiation dose (BED ≥ 180 Gy2).